13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 53 holding rows worth $999,389,000.
- Accession
- 0001567619-19-004400
- Filer
- CIK 1587114
- Filed
- 2019-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2018
A holdings report, 54 entries on the cover page, a total value of $999,389,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $999,389,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 825,087 | $79,266,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 5,276,753 | $74,086,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 1,524,557 | $70,556,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 5,381,282 | $55,750,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,404,853 | $54,398,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 1,136,851 | $44,496,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 679,746 | $42,586,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 725,326 | $39,211,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q908 | CALL | 840,800 | $38,912,000 | thousands by filing date | call |
| XENCOR INC | 98401F105 | COMMON STOCK | 989,018 | $35,763,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 3,316,407 | $35,452,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 1,474,228 | $33,863,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 647,169 | $27,453,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,060,018 | $25,016,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 867,246 | $23,242,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S | 04351P951 | PUT | 360,000 | $22,554,000 | thousands by filing date | put |
| AKCEA THERAPEUTICS INC | 00972L107 | COM | 639,743 | $19,282,000 | thousands by filing date | |
| GILEAD SCIENCES INC | 375558903 | COM | 285,100 | $17,833,000 | thousands by filing date | call |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 1,595,643 | $16,212,000 | thousands by filing date | |
| UNITY BIOTECHNOLOGY INC | 91381U101 | COM | 967,114 | $15,725,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S | 04351P901 | CALL | 250,400 | $15,688,000 | thousands by filing date | call |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,185,831 | $13,613,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 569,377 | $13,221,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,223,495 | $13,177,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 3,281,502 | $12,568,000 | thousands by filing date | |
| CELGENE CORP | 151020904 | COM | 195,000 | $12,498,000 | thousands by filing date | call |
| IRONWOOD PHARMACEUTICALS INC | 46333X908 | COM CL A | 1,172,300 | $12,145,000 | thousands by filing date | call |
| MYOKARDIA INC | 62857M105 | COM | 234,381 | $11,452,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 400,838 | $10,775,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS CMN STK | 640268908 | Cmn | 316,700 | $10,410,000 | thousands by filing date | call |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 233,933 | $9,835,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 2,261,328 | $9,588,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 592,128 | $9,521,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 644,002 | $9,177,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 838,219 | $8,634,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 1,379,487 | $7,863,000 | thousands by filing date | |
| IMMUNE DESIGN CORP. | 45252L103 | Common Stock | 5,603,191 | $7,284,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 450,000 | $6,669,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 208,850 | $5,967,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 2,265,880 | $4,894,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 247,858 | $4,838,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 613,728 | $4,535,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 326,775 | $3,039,000 | thousands by filing date | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 166,005 | $2,218,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 2,982,208 | $2,057,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 140,118 | $1,282,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 379,753 | $1,181,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 295,420 | $1,084,000 | thousands by filing date | |
| ONCONOVA THERAPEUTIC | 68232V405 | Common Stock | 423,441 | $893,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 50,000 | $643,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 158,221 | $492,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 79,194 | $318,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 11,022 | $174,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-19-004400 | this filing | 2019-02-14 | acceptance time not in the bulk data set |